We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Flags Ethical Concerns for Placebos and Blinding in Trials
FDA Flags Ethical Concerns for Placebos and Blinding in Trials
The FDA shared its latest thinking on the use of placebos in oncology trials in a final guidance released Wednesday, highlighting ethical concerns about the use of “sham surgical procedures.”